S'identifier

Chapter 3

Lower Respiratory Tract Infections

Pneumonie I : Introduction
Pneumonie I : Introduction
Pneumonia is a lung parenchymal infection that affects one or both lungs. Risk factors for pneumonia include air pollution, smoking, corticosteroid and ...
Pneumonie II : Physiopathologie
Pneumonie II : Physiopathologie
Pneumonia follows a sequence of pathophysiological changes. The process begins when pathogens enter the respiratory tract through various means, such as ...
Pneumonie III : complications et évaluation
Pneumonie III : complications et évaluation
Pneumonia can lead to complications like hypotension, pleural effusion, atelectasis, pneumothorax, and respiratory failure, especially without timely ...
Pneumonie IV : Prise en charge
Pneumonie IV : Prise en charge
Effective pneumonia management includes the following: Pharmacological treatment for pneumonia involves oral or intravenous antibiotics for bacterial ...
Pneumonie V : prise en charge et prévention des soins infirmiers
Pneumonie V : prise en charge et prévention des soins infirmiers
Nursing management of a patient with pneumonia includes the following interventions. Nurses must adhere to medical asepsis and infection control ...
Tuberculose pulmonaire I
Tuberculose pulmonaire I
Tuberculosis or TB is an infectious disease caused by Mycobacterium tuberculosis primarily affecting the lung parenchyma. It can also affect other body ...
Tuberculose pulmonaire II
Tuberculose pulmonaire II
The pathophysiology of tuberculosis begins when a susceptible host inhales aerosolized droplets containing Mycobacterium tuberculosis. The droplets reach ...
Tuberculose pulmonaire III
Tuberculose pulmonaire III
Tuberculosis can be classified into the following six categories based on disease progression: Class zero indicates no known tuberculosis exposure with a ...
Tuberculose pulmonaire IV
Tuberculose pulmonaire IV
Diagnosing tuberculosis involves a series of tests. The initial method is the Mantoux tuberculin skin test, which entails injecting a small amount of ...
Tuberculose pulmonaire V
Tuberculose pulmonaire V
Collaborative care for pulmonary tuberculosis involves a prolonged medication course tailored to drug-susceptible or drug-resistant tuberculosis. ...
Insuffisance respiratoire aiguë-I
Insuffisance respiratoire aiguë-I
Acute respiratory failure develops when the respiratory system fails to meet the body's oxygenation, ventilation, or metabolic requirements. It can ...
Insuffisance respiratoire aiguë-II
Insuffisance respiratoire aiguë-II
Type 1 hypoxemic respiratory failure occurs due to an inadequate oxygen supply, characterized by a partial pressure of oxygen below 60 milliliters of ...
Insuffisance respiratoire aiguë-III
Insuffisance respiratoire aiguë-III
Type 2 or hypercapnic respiratory failure occurs due to increased carbon dioxide production or decreased alveolar ventilation. It is characterized by ...
Insuffisance respiratoire aiguë-IV
Insuffisance respiratoire aiguë-IV
Clinical manifestations of acute respiratory failure include the following: Initial manifestations like restlessness and confusion indicate inadequate ...
Insuffisance respiratoire aiguë-V
Insuffisance respiratoire aiguë-V
Managing acute respiratory failure necessitates a collaborative approach. Respiratory therapy aims to optimize oxygenation and ventilation while ...
JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.